D.E. Shaw & Co
UTHR icon

D.E. Shaw & Co’s United Therapeutics UTHR Stock Holding History

D.E. Shaw & Co’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.8M Sell
99,106
-207,865
-68% -$104M 0.04% 587
2025
Q4 		$150M Buy
306,971
+242,260
+374% +$113M 0.08% 280
2025
Q3 		$27.1M Buy
64,711
+43,103
+199% +$14.5M 0.02% 978
2025
Q2 		$6.21M Sell
21,608
-8,658
-29% -$2.59M ﹤0.01% 1863
2025
Q1 		$9.33M Sell
30,266
-13,022
-30% -$4.46M 0.01% 1457
2024
Q4 		$15.3M Sell
43,288
-8,262
-16% -$3.04M 0.01% 1217
2024
Q3 		$18.5M Buy
51,550
+9,529
+23% +$3.22M 0.02% 1034
2024
Q2 		$13.4M Sell
42,021
-211
-0.5% -$55.8K 0.01% 1152
2024
Q1 		$9.7M Sell
42,232
-47,467
-53% -$10.7M 0.01% 1381
2023
Q4 		$19.7M Buy
89,699
+4,613
+5% +$1.06M 0.02% 929
2023
Q3 		$19.2M Sell
85,086
-3,736
-4% -$861K 0.02% 874
2023
Q2 		$19.6M Sell
88,822
-78,905
-47% -$17.5M 0.02% 875
2023
Q1 		$37.6M Buy
167,727
+4,415
+3% +$1.09M 0.04% 545
2022
Q4 		$45.4M Buy
163,312
+126,512
+344% +$31.9M 0.05% 473
2022
Q3 		$7.71M Sell
36,800
-50,832
-58% -$11.4M 0.01% 1599
2022
Q2 		$20.6M Sell
87,632
-11,684
-12% -$2.38M 0.02% 851
2022
Q1 		$17.8M Sell
99,316
-80,391
-45% -$15.3M 0.02% 1116
2021
Q4 		$38.8M Sell
179,707
-107,720
-37% -$21.1M 0.03% 684
2021
Q3 		$53.1M Sell
287,427
-102,121
-26% -$20.1M 0.05% 500
2021
Q2 		$69.9M Buy
389,548
+16,086
+4% +$3.06M 0.06% 389
2021
Q1 		$62.5M Sell
373,462
-110,854
-23% -$18.5M 0.06% 390
2020
Q4 		$73.5M Sell
484,316
-175,340
-27% -$23M 0.07% 357
2020
Q3 		$66.6M Buy
659,656
+159,354
+32% +$17.5M 0.07% 333
2020
Q2 		$60.5M Sell
500,302
-93,396
-16% -$10.5M 0.07% 304
2020
Q1 		$56.3M Sell
593,698
-365,473
-38% -$34.7M 0.09% 260
2019
Q4 		$84.5M Buy
959,171
+45,115
+5% +$3.97M 0.1% 239
2019
Q3 		$72.9M Buy
914,056
+80,708
+10% +$6.5M 0.09% 267
2019
Q2 		$65.1M Buy
833,348
+558,275
+203% +$52.2M 0.08% 304
2019
Q1 		$32.3M Sell
275,073
-162,003
-37% -$18.9M 0.04% 514
2018
Q4 		$47.6M Buy
437,076
+33,763
+8% +$3.91M 0.07% 363
2018
Q3 		$51.6M Buy
403,313
+43,393
+12% +$5.37M 0.06% 389
2018
Q2 		$40.7M Sell
359,920
-52,272
-13% -$5.75M 0.05% 438
2018
Q1 		$46.3M Sell
412,192
-188,948
-31% -$24M 0.06% 373
2017
Q4 		$88.9M Buy
601,140
+46,063
+8% +$5.86M 0.12% 201
2017
Q3 		$65M Buy
555,077
+161,936
+41% +$20.7M 0.1% 244
2017
Q2 		$51M Buy
393,141
+105,312
+37% +$13.1M 0.08% 286
2017
Q1 		$39M Sell
287,829
-92,311
-24% -$14M 0.07% 345
2016
Q4 		$54.5M Buy
380,140
+24,455
+7% +$3.12M 0.09% 260
2016
Q3 		$42M Buy
355,685
+133,097
+60% +$16M 0.07% 334
2016
Q2 		$23.6M Sell
222,588
-171,372
-43% -$19.1M 0.04% 489
2016
Q1 		$43.9M Sell
393,960
-60,251
-13% -$7.62M 0.08% 297
2015
Q4 		$71.1M Buy
454,211
+71,092
+19% +$10.3M 0.11% 224
2015
Q3 		$50.3M Buy
383,119
+127,605
+50% +$20.5M 0.07% 310
2015
Q2 		$44.4M Buy
255,514
+166,415
+187% +$29.9M 0.07% 349
2015
Q1 		$15.4M Sell
89,099
-161,343
-64% -$24.6M 0.02% 721
2014
Q4 		$32.4M Buy
+250,442
New +$32.3M 0.04% 500
2014
Q2 		– Sell
-48,339
Closed -$4.54M – 4547
2014
Q1 		$4.54M Sell
48,339
-11,661
-19% -$1.19M 0.01% 1669
2013
Q4 		$6.79M Buy
+60,000
New +$5.41M 0.01% 1435

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

D.E. Shaw & Co's UTHR Position: Q1 2026 in Review

D.E. Shaw & Co reduced its United Therapeutics (UTHR) stake by 68% in Q1 2026, selling an estimated $104M and leaving 99,106 shares worth $58.8M. The position accounts for 0.04% of the portfolio, ranked #587.

D.E. Shaw & Co first reported a position in UTHR in Q4 2013 and has held it in 48 quarters since. The position peaked at $150M in Q4 2025. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • D.E. Shaw & Co held 99,106 shares of United Therapeutics worth $58.8M as of Q1 2026.
  • D.E. Shaw & Co sold 207,865 United Therapeutics shares in Q1 2026, an estimated $104M.
  • United Therapeutics made up 0.04% of D.E. Shaw & Co's portfolio in Q1 2026, its #587 holding.
  • D.E. Shaw & Co first reported a position in United Therapeutics in Q4 2013 and has held it in 48 quarters since.
  • D.E. Shaw & Co's United Therapeutics position peaked at $150M in Q4 2025.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.